You just read:

Oncternal Therapeutics' TK216 Receives Orphan Drug Designation for the Treatment of Ewing Sarcoma, a Rare Pediatric Cancer

News provided by

Oncternal Therapeutics, Inc.

13 Jul, 2016, 07:15 ET